| PubMed | Title | Journal | Year | Linked by |
|---|
| PMID 40991122 | Eladocagene Exuparvovec for the Treatment of Aromatic L-Amino Acid Decarboxylase Deficiency (AADCd): An Economic Evaluation from a US Perspective. | PharmacoEconomics | 2026 | name in title: eladocagene exuparvovec |
| PMID 42137299 | Advancing AADC deficiency therapy through MR-guided multisite delivery of AAV2-hAADC to dopaminergic and serotonergic pathways in the brainstem. | Molecular therapy. Advances | 2026 | name in title: AAV2-hAADC |
| PMID 42389831 | Gene Therapy for Amino Acid Decarboxylase Deficiency: Clinical and Imaging Outcomes in a French Cohort. | Movement disorders : official journal of the Movement Disorder Society | 2026 | name in abstract: eladocagene exuparvovec |
| PMID 42449943 | Trends in the Engineering of Adeno-Associated Virus (AAV) for Precision Gene Delivery to the Central Nervous System (CNS). | International journal of molecular sciences | 2026 | name in abstract: Kebilidi |
| PMID 39435566 | Optimizing the anesthetic care of patients with aromatic l-amino acid decarboxylase deficiency. | Paediatric anaesthesia | 2025 | name in abstract: eladocagene exuparvovec |
| PMID 39743428 | Kebilidi (eladocagene exuparvovec-tneq). | Clinical therapeutics | 2025 | name in title: eladocagene exuparvovec |
| PMID 39849575 | Estimating health state utilities for aromatic L-amino acid decarboxylase deficiency (AADCd) in the United States. | Health and quality of life outcomes | 2025 | name in abstract: eladocagene exuparvovec |
| PMID 39920752 | Clinically meaningful improvements after gene therapy for aromatic L-amino acid decarboxylase deficiency (AADCd) in the Peabody Developmental Motor Scale, Second Edition (PDMS-2) and correlation with Bayley-III scores and motor milestones. | Orphanet journal of rare diseases | 2025 | name in abstract: eladocagene exuparvovec |
| PMID 40072415 | Eladocagene Exuparvovec for Aromatic L-Amino Acid Decarboxylase Deficiency. | JAMA | 2025 | name in title: eladocagene exuparvovec |
| PMID 40895248 | The Next Frontier in Parkinson's Disease Treatment: A Narrative Review of Innovative Neurosurgical and Gene Therapy Approaches. | Health science reports | 2025 | name in abstract: AAV2-hAADC |
| PMID 37402126 | Gene therapy for aromatic L-amino acid decarboxylase deficiency: Requirements for safe application and knowledge-generating follow-up. | Journal of inherited metabolic disease | 2024 | name in abstract: eladocagene exuparvovec |
| PMID 38238766 | A position statement on the post gene-therapy rehabilitation of aromatic I-amino acid decarboxylase deficiency patients. | Orphanet journal of rare diseases | 2024 | name in abstract: eladocagene exuparvovec |
| PMID 39180957 | Immune responses to central nervous system directed adeno-associated virus gene therapy: Does direct CNS delivery make a difference? | Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2024 | name in abstract: Upstaza |
| PMID 36472076 | AAV2-hAADC (Eladocagene Exuparvovec) Biodistribution and Expression: Superiority of Intraputaminal versus Intracerebroventricular and Intrathecal (Lumbar) Routes of Administration. | International journal of toxicology | 2023 | name in title: eladocagene exuparvovec |
| PMID 36736907 | AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges. | Journal of controlled release : official journal of the Controlled Release Society | 2023 | name in abstract: Upstaza |
| PMID 37147851 | Gene Therapy for Dopamine Dyshomeostasis: From Parkinson's to Primary Neurotransmitter Diseases. | Movement disorders : official journal of the Movement Disorder Society | 2023 | name in abstract: eladocagene exuparvovec |
| PMID 37205256 | Intraputaminal Gene Delivery in Two Patients with Aromatic L-Amino Acid Decarboxylase Deficiency. | Movement disorders clinical practice | 2023 | name in abstract: eladocagene exuparvovec |
| PMID 37803205 | Long-Term Outcomes of Eladocagene Exuparvovec Compared with Standard of Care in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Modelling Study. | Advances in therapy | 2023 | name in title: eladocagene exuparvovec |
| PMID 38462459 | Viral Vectors in Gene Replacement Therapy. | Biochemistry. Biokhimiia | 2023 | name in abstract: Upstaza |
| PMID 36103022 | Eladocagene Exuparvovec: First Approval. | Drugs | 2022 | name in title: eladocagene exuparvovec |
| PMID 39086961 | Strategies to improve safety profile of AAV vectors. | Frontiers in molecular medicine | 2022 | name in abstract: Upstaza |
| PMID 34285619 | Eliciting Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Vignette Study in France. | Patient related outcome measures | 2021 | name in abstract: eladocagene exuparvovec |
| PMID 28166239 | Depletion of AADC activity in caudate nucleus and putamen of Parkinson's disease patients; implications for ongoing AAV2-AADC gene therapy trial. | PloS one | 2017 | name in abstract: AAV2-hAADC |
| PMID 25860990 | Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats. | PloS one | 2015 | name in title: AAV2-hAADC |
| PMID 25541617 | SAFETY AND TOLERABILITY OF MRI-GUIDED INFUSION OF AAV2-hAADC INTO THE MID-BRAIN OF NON-HUMAN PRIMATE. | Molecular therapy. Methods & clinical development | 2014 | name in title: AAV2-hAADC |
| PMID 22017504 | Safety and tolerability of magnetic resonance imaging-guided convection-enhanced delivery of AAV2-hAADC with a novel delivery platform in nonhuman primate striatum. | Human gene therapy | 2012 | name in title: AAV2-hAADC |
| PMID 21430597 | T2 imaging in monitoring of intraparenchymal real-time convection-enhanced delivery. | Neurosurgery | 2011 | name in abstract: AAV2-hAADC |
| PMID 20531394 | Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC. | Molecular therapy : the journal of the American Society of Gene Therapy | 2010 | name in title: AAV2-hAADC |
| PMID 19095069 | Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. | NeuroImage | 2009 | name in abstract: AAV2-hAADC |
| PMID 18523450 | Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain. | Molecular therapy : the journal of the American Society of Gene Therapy | 2008 | name in abstract: AAV2-hAADC |
| PMID 16407771 | Distribution of AAV2-hAADC-transduced cells after 3 years in Parkinsonian monkeys. | Neuroreport | 2006 | name in title: AAV2-hAADC |